Growth of prolactinoma despite lowering of serum prolactin by bromocriptine

M. J. Kupersmith, D. Kleinberg, F. A. Warren, G. Budzilovitch, P. Cooper

Research output: Contribution to journalArticlepeer-review

21 Scopus citations


Four patients with macroprolactinomas treated with bromocriptine had tumor growth and visual loss despite marked reduction in their serum prolactin levels. Explanations for this dissociation of tumor growth and prolactin measurement might include noncompliance. patients treated with bromocriptine require periodic examination by computed tomographic scan or magnetic resonance imaging and neuro-ophthalmological evaluation in addition to monitoring of serum prolactin.

Original languageEnglish
Pages (from-to)417-423
Number of pages7
Issue number3
StatePublished - 1989
Externally publishedYes


Dive into the research topics of 'Growth of prolactinoma despite lowering of serum prolactin by bromocriptine'. Together they form a unique fingerprint.

Cite this